PDI, Inc. (NASDAQ:PDII)

CAPS Rating: No stars

A sales and marketing services company, which serves the biopharmaceutical and life sciences industries.

Recs

1
Player Avatar no1spec1al (< 20) Submitted: 4/22/2007 9:10:39 PM : Outperform Start Price: $9.40 PDII Score: -95.62

Trading below book value, new management. Their price was beaten down for loss of a large contract, but they've since picked up another. Not profitable at the moment, but with the company trading below book value your risks are pretty low. With the new sales director this stock can only get better.

Featured Broker Partners


Advertisement